337 related articles for article (PubMed ID: 16125709)
1. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
2. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
5. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
7. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
8. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
[TBL] [Abstract][Full Text] [Related]
9. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica.
Ruiz-Narváez EA; Yang Y; Nakanishi Y; Kirchdorfer J; Campos H
J Lipid Res; 2005 Dec; 46(12):2605-13. PubMed ID: 16192625
[TBL] [Abstract][Full Text] [Related]
10. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
11. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL; Fang WH; Wen HC; Lin HP; Lin YL; Lin SW; Wu JH; Kao JT
Clin Chim Acta; 2008 Apr; 390(1-2):56-62. PubMed ID: 18206649
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
14. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
15. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
16. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.
Olivier M; Wang X; Cole R; Gau B; Kim J; Rubin EM; Pennacchio LA
Genomics; 2004 May; 83(5):912-23. PubMed ID: 15081120
[TBL] [Abstract][Full Text] [Related]
17. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
18. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
Liu S; Song Y; Hu FB; Niu T; Ma J; Gaziano M; Stampfer MJ
Atherosclerosis; 2004 Nov; 177(1):119-26. PubMed ID: 15488874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
